Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Vinicius Tieppo Francio

Pain Medicine Saint Louis, MO Medical Doctor

NPI 1811311434 CMS profile 1155300

4921 Parkview Pl, Dept Anesthesiology, Ste 14C, Saint Louis, MO 63110

Open in the dashboard

General payments

$35,473

202 records reported · program years 2022–2025

Research payments

$3,000

Paid to them · 1 record reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$10,500 paid to institutions, not to them · program year 2023

Through program year 2025, Vinicius Tieppo Francio of Saint Louis, MO is reported in the CMS Open Payments database as having received $35,473 across 202 general payments and $3,000 in research payments paid to them. Separately, studies naming them as principal investigator received $10,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,894 97
2024 General $9,938 71
2023 General $13,103 30
2022 General $537 4
2022 Research $3,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vinicius Tieppo Francio
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Vinicius Tieppo Francio were reported at $11,894. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Vinicius Tieppo Francio Pain Medicine median Middle half National median
2019 $0 $498 $126–$1,682 $163
2020 $0 $284 $80–$910 $114
2021 $0 $399 $112–$1,219 $132
2022 $537 $455 $137–$1,484 $149
2023 $13,103 $484 $128–$1,495 $160
2024 $9,938 $498 $131–$1,540 $164
2025 $11,894 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $13,488 52 payments
  2. MML US, Inc. $9,137 34 payments
  3. Abbott Laboratories $3,437 29 payments
  4. Boston Scientific Corporation $2,761 17 payments
  5. Saluda Medical Americas, Inc. $2,623 16 payments
  6. Nevro Corp. $948 14 payments
  7. Globus Medical, Inc. $692 17 payments
  8. Nalu Medical, Inc. $452 4 payments
  9. Spinal Simplicity, LLC $388 3 payments
  10. SPR Therapeutics, Inc $373 4 payments
  11. Other $1,174 12 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $10,981 157 payments
  2. Grant $10,000 1 payment
  3. Travel and Lodging $8,928 39 payments
  4. Consulting Fee $5,564 5 payments
Products named General payments · program years 2022–2025
  1. SYNCHROMEDII $10,020 2 payments
  2. ReActiv8 $9,137 34 payments
  3. Evoke $2,623 16 payments
  4. PROCLAIM $2,472 15 payments
  5. INTELLIS ADAPTIVESTIM $1,712 25 payments
  6. VANTA ADAPTIVESTIM $1,534 18 payments
  7. Senza Spinal Cord Stimulator $948 14 payments
  8. Vercise $772 5 payments
  9. Senza Spinal Cord Stimulator $678 16 payments
  10. Nalu Neurostimulation System $452 4 payments
  11. Other $3,609 46 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2022–2025
  1. Nevro Corp. $3,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

51

Median for Anesthesiology: 322

Drug cost

$541

Median for Anesthesiology: $8,738

Branded share of claims

45.1%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 16 $274
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $146
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $84
Tizanidine Hcl Generic 12 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$12,318

Medicare's payments for the services billed

Medicare patients

64

Average age 68

Services billed

193

41 women, 23 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Depression 31%
Ischemic heart disease 27%
Osteoporosis 27%
Heart failure 23%
Chronic kidney disease 23%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

203 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record